BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BAY 59-8862 in treating patients who have non-small cell lung cancer.

Timeline

Start

2002-03

Primary completion

2003-04

Completion

—

Drugs

Indications